12:00 AM
 | 
Feb 02, 2015
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Takeda Pharmaceuticals Co. Ltd. sales and marketing update

Takeda launched IV fomepizole in Japan to treat ethylene glycol and methanol poisoning. Takeda has exclusive, Japanese rights to develop and commercialize the product under a...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >